Longevity Health Holdings, Inc.

XAGE OTC SEC CIK 1842939
Follow Longevity Health Weekly email: filings, results

Financials

Reported figures only · latest: Q2 2026 USD · US GAAP
Revenue, last quarter $396K −21.4% vs same quarter last year
Net income −$1.9M +0.2% vs same quarter last year
EPS, diluted −$0.76 +51.3% vs same quarter last year
Operating cash flow −$223.9K +73.2% vs same quarter last year
Revenue by quarter
$20.5K
$17.5K
$510.4K
$503.6K
$425.9K
$473K
$391.8K
$396K
Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income5 fiscal years
  • Revenue
  • Net income
−$20M−$15M−$10M−$5M$0$5MFY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$1.9M−$6.9M
FY24$50.3K−$10.4M
FY23$0−$15.4M
FY22-−$9.1M
FY21--
Free cash flowOperating cash flow minus capital expenditure
−$10M−$7.5M−$5M−$2.5M$0FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$3.3M
FY24-
FY23−$8.4M
FY22−$3.4M
FY21-